The pharmaceutical industry is facing a number of challenges during the current economic downturn which create a strong requirement for the pro-active protection of company information and assets.
Long standing issues surrounding data exclusivity and patents are ongoing debates within the industry and are increasingly important issues in the face of rising R&D costs. The need to be first to market to secure sizable profit margins has led to a highly competitive global industry. For a sector so rich in IP it is imperative that the threat of corporate espionage is considered seriously.
The lengthy and costly process of clinical trials, ongoing innovative productivity challenges and fierce legal patent disputes are becoming commonplace. The need to protect sensitive corporate information against corrupt or improper activity has never been more important.
Our extensive experience in providing strategic board level support to global corporations has helped many of our pharmaceutical clients to realise the value of having peace of mind in outsourcing their business resilience planning to Esoteric. Our clients are able to concentrate on core business activity, safe in the knowledge that the threat of attempted or actual attacks from competitors, criminals and terrorists has been minimised.